| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.094 | 0.1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |